Stanford University Orders a Cease and Desist Letter to Nu Skin Enterprises To Stop Using Researcher’s Name in Company Adv
Posted Aug 20 2012 12:39am
If you have not heard of the product it is sold via multi marketing and they have a variety of products to include vitamins and other products for better skin appearance. It is almost like an Amway type of company with distributorships and a similar culture. Evidently Stanford wants their researcher’s name removed from company advertising. In addition to the Galvonic facial device there could be other products that could need FDA approval and once again this all comes back to the way products get advertised today. If devices and products are making “medical” claims, then the FDA says send in your paperwork.
Stanford has had a relationship with Nu Skin and has funded studies at the university and has a separate relationship with the company in their dermatology department. We have seen advertising challenged before and one case in particular that was kind of funny was Cheerios with their advertising to where they had to make a change or file papers as “drugs” are required to do with the FDA. BD
WASHINGTON/NEW YORK — Stanford University has sent a "cease and desist" letter to Nu Skin Enterprises Inc asking the company to stop using a university researcher's name in its advertising, adding new scrutiny to the skin product maker's business claims and practices. According to a copy of the letter e-mailed to Reuters, Stanford geneticist Stuart Kim is listed as a "Nu Skin Partner" in developing its ageLOC anti-ageing products, though he has nothing to do with the company. Nu Skin touts its skin creams and pills as using innovative technology to "reset" genes that promote a more youthful look and feel for its clients, according to its website. "Neither Dr Kim nor Stanford is a 'Nu Skin Partner' and neither has anything to do with the company," states the letter, signed by Steven Rosen from Stanford's Office of the General Counsel.
A Stanford spokesman said the university's dermatology department has a separate, long-standing relationship with Nu Skin, including a clinical trial in progress. Nu Skin said its relationship with Stanford began in 1999. In 2009, it gave $1.5 million to a study on human skin ageing with Kim and other scientists. Kim later left the study, but two dermatologists, Dr Anne Chang and Dr Alfred Lane, continue to work on the study, Nu Skin said.
In a regulatory filing last week, Nu Skin said the FDA had recently stopped shipments of the company's Galvanic Spa facial treatments, which use an electric device to deliver a purifying skin gel. The agency now believes the product could require clearance as a medical device. In a further update on Thursday, the company said it has stopped all imports of the Galvanic treatments and was prepared to register the product as a medical device. The FDA clearance could take 6 to 9 months, the company said.